I think with NEU being de-risked and cash flow positive, the upside for Neuren is unlike many of the stocks currently on the ASX. Putting this into perspective we look at the cash flow hitting our accounts over the next 5 years and the potential for NNZ2591, we could really hit the jackpot. Partnering with Acadia has been a good idea and they have hit the ground running. Brokers will be all over this recent announcement and most importantly, the register of the 129 Million shares, comparing against loads of mining stocks with billions of shares, we are in the drivers seat for serious share price appreciation.
Each quarter we will receive updates on uptake of the Retts Dayblue cash flow as well as updates on NNZ2591.
if you look at the top twenty shareholders and work out how many shares are in this, it doesn’t leave a lot for trading. There has been a lot of profit takers (holders that have been in the stock for more than 10 years) and loads that have held their shares (such as myself) waiting for the holy grail to get to market. (NNZ2591)
It should be an interesting week ahead from a volume perspective. Perhaps @ slick could put his skills to the test. I see $15.20 being hit next week.
The next 6-12 months will be game changing and I see increments of an increase of $3.00 per share per quarter as conservative and hence why I am looking to purchase large chunks on any fall.
The best thing about owning this stock is knowing that Neuren and it’s shareholders are making lives better for the Retts girls, and making lives easier for those that hold the stock and seeing their wealth increase exponentially.
Neuren management are world class, never missing timelines and always looking for ways to improve others lives. I’m all in!
NEU Price at posting:
$13.59 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)